APO Research

APO RESEARCH · REPORT

Hyaluronic Acid for Osteoarthritis

Selected research

Market Structure

Global Hyaluronic Acid for Osteoarthritis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Hyaluronic Acid for Osteoarthritis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hyaluronic Acid for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hyaluronic Acid for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hyaluronic Acid for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hyaluronic Acid for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hyaluronic Acid for Osteoarthritis include BIOVENTUS, Anika Therapeutics, BIOIBERICA, Biolevox, Bohus BioTech, Fidia Farma, Hangzhou Singclean Medical Products, ideolab and LG Chem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hyaluronic Acid for Osteoarthritis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hyaluronic Acid for Osteoarthritis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hyaluronic Acid for Osteoarthritis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hyaluronic Acid for Osteoarthritis market size, projected growth trends, production technologies, key applications, and end-use industries.

Hyaluronic Acid for Osteoarthritis Segment by Company

BIOVENTUS

Anika Therapeutics

BIOIBERICA

Biolevox

Bohus BioTech

Fidia Farma

Hangzhou Singclean Medical Products

ideolab

LG Chem

Vivacy

Xediton Pharmaceuticals

Deka

Ferring B.V.

Sanofi

Hyaluronic Acid for Osteoarthritis Segment by Type

Single-Phase

Duplex

Hyaluronic Acid for Osteoarthritis Segment by Application

Knee Joint

Hip Joint

Shoulder Joint

Ankle Joint

Others

Hyaluronic Acid for Osteoarthritis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyaluronic Acid for Osteoarthritis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyaluronic Acid for Osteoarthritis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyaluronic Acid for Osteoarthritis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hyaluronic Acid for Osteoarthritis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hyaluronic Acid for Osteoarthritis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hyaluronic Acid for Osteoarthritis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hyaluronic Acid for Osteoarthritis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hyaluronic Acid for Osteoarthritis Industry Trends Table 2. Hyaluronic Acid for Osteoarthritis Industry Drivers Table 3. Hyaluronic Acid for Osteoarthritis Industry Opportunities and Challenges Table 4. Hyaluronic Acid for Osteoarthritis Industry Restraints Table 5. Global Hyaluronic Acid for Osteoarthritis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hyaluronic Acid for Osteoarthritis Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Manufacturers Table 9. Global Hyaluronic Acid for Osteoarthritis Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hyaluronic Acid for Osteoarthritis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hyaluronic Acid for Osteoarthritis Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hyaluronic Acid for Osteoarthritis Manufacturers, Product Type & Application Table 13. Global Hyaluronic Acid for Osteoarthritis Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hyaluronic Acid for Osteoarthritis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single-Phase Table 17. Major Manufacturers of Duplex Table 18. Global Hyaluronic Acid for Osteoarthritis Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021-2026) & (W Units) Table 20. Global Hyaluronic Acid for Osteoarthritis Sales by Type (2027-2032) & (W Units) Table 21. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2021-2026) Table 22. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2027-2032) Table 23. Global Hyaluronic Acid for Osteoarthritis Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2021-2026) & (W Units) Table 25. Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2027-2032) & (W Units) Table 26. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2021-2026) Table 27. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Knee Joint Table 29. Major Manufacturers of Hip Joint Table 30. Major Manufacturers of Shoulder Joint Table 31. Major Manufacturers of Ankle Joint Table 32. Major Manufacturers of Others Table 33. Global Hyaluronic Acid for Osteoarthritis Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021-2026) & (W Units) Table 35. Global Hyaluronic Acid for Osteoarthritis Sales by Application (2027-2032) & (W Units) Table 36. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2021-2026) Table 37. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2027-2032) Table 38. Global Hyaluronic Acid for Osteoarthritis Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2021-2026) & (W Units) Table 40. Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2027-2032) & (W Units) Table 41. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2021-2026) Table 42. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2027-2032) Table 43. Global Hyaluronic Acid for Osteoarthritis Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Hyaluronic Acid for Osteoarthritis Sales by Region (2021-2026) & (W Units) Table 45. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Region (2021-2026) Table 46. Global Hyaluronic Acid for Osteoarthritis Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Hyaluronic Acid for Osteoarthritis Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2026) & (W Units) Table 50. North America Hyaluronic Acid for Osteoarthritis Sales by Country (2027-2032) & (W Units) Table 51. Europe Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2026) & (W Units) Table 53. Europe Hyaluronic Acid for Osteoarthritis Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Hyaluronic Acid for Osteoarthritis Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales by Country (2027-2032) & (W Units) Table 60. Global Hyaluronic Acid for Osteoarthritis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hyaluronic Acid for Osteoarthritis Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Hyaluronic Acid for Osteoarthritis Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Region (2021-2026) Table 64. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Region (2027-2032) Table 65. BIOVENTUS Company Information Table 66. BIOVENTUS Business Overview Table 67. BIOVENTUS Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BIOVENTUS Hyaluronic Acid for Osteoarthritis Product Portfolio Table 69. BIOVENTUS Recent Development Table 70. Anika Therapeutics Company Information Table 71. Anika Therapeutics Business Overview Table 72. Anika Therapeutics Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Anika Therapeutics Hyaluronic Acid for Osteoarthritis Product Portfolio Table 74. Anika Therapeutics Recent Development Table 75. BIOIBERICA Company Information Table 76. BIOIBERICA Business Overview Table 77. BIOIBERICA Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BIOIBERICA Hyaluronic Acid for Osteoarthritis Product Portfolio Table 79. BIOIBERICA Recent Development Table 80. Biolevox Company Information Table 81. Biolevox Business Overview Table 82. Biolevox Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Biolevox Hyaluronic Acid for Osteoarthritis Product Portfolio Table 84. Biolevox Recent Development Table 85. Bohus BioTech Company Information Table 86. Bohus BioTech Business Overview Table 87. Bohus BioTech Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bohus BioTech Hyaluronic Acid for Osteoarthritis Product Portfolio Table 89. Bohus BioTech Recent Development Table 90. Fidia Farma Company Information Table 91. Fidia Farma Business Overview Table 92. Fidia Farma Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Fidia Farma Hyaluronic Acid for Osteoarthritis Product Portfolio Table 94. Fidia Farma Recent Development Table 95. Hangzhou Singclean Medical Products Company Information Table 96. Hangzhou Singclean Medical Products Business Overview Table 97. Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Product Portfolio Table 99. Hangzhou Singclean Medical Products Recent Development Table 100. ideolab Company Information Table 101. ideolab Business Overview Table 102. ideolab Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. ideolab Hyaluronic Acid for Osteoarthritis Product Portfolio Table 104. ideolab Recent Development Table 105. LG Chem Company Information Table 106. LG Chem Business Overview Table 107. LG Chem Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. LG Chem Hyaluronic Acid for Osteoarthritis Product Portfolio Table 109. LG Chem Recent Development Table 110. Vivacy Company Information Table 111. Vivacy Business Overview Table 112. Vivacy Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Vivacy Hyaluronic Acid for Osteoarthritis Product Portfolio Table 114. Vivacy Recent Development Table 115. Xediton Pharmaceuticals Company Information Table 116. Xediton Pharmaceuticals Business Overview Table 117. Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Product Portfolio Table 119. Xediton Pharmaceuticals Recent Development Table 120. Deka Company Information Table 121. Deka Business Overview Table 122. Deka Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Deka Hyaluronic Acid for Osteoarthritis Product Portfolio Table 124. Deka Recent Development Table 125. Ferring B.V. Company Information Table 126. Ferring B.V. Business Overview Table 127. Ferring B.V. Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Ferring B.V. Hyaluronic Acid for Osteoarthritis Product Portfolio Table 129. Ferring B.V. Recent Development Table 130. Sanofi Company Information Table 131. Sanofi Business Overview Table 132. Sanofi Hyaluronic Acid for Osteoarthritis Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Sanofi Hyaluronic Acid for Osteoarthritis Product Portfolio Table 134. Sanofi Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Hyaluronic Acid for Osteoarthritis Distributors List Table 138. Hyaluronic Acid for Osteoarthritis Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Hyaluronic Acid for Osteoarthritis Product Image Figure 2. Global Hyaluronic Acid for Osteoarthritis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyaluronic Acid for Osteoarthritis Market Size (2021-2032) & (US$ Million) Figure 4. Global Hyaluronic Acid for Osteoarthritis Sales (2021-2032) & (W Units) Figure 5. Global Hyaluronic Acid for Osteoarthritis Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hyaluronic Acid for Osteoarthritis Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single-Phase Image Figure 9. Duplex Image Figure 10. Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Hyaluronic Acid for Osteoarthritis Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2021-2032) Figure 13. Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2021-2032) Figure 16. Knee Joint Image Figure 17. Hip Joint Image Figure 18. Shoulder Joint Image Figure 19. Ankle Joint Image Figure 20. Others Image Figure 21. Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Hyaluronic Acid for Osteoarthritis Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2021-2032) Figure 24. Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2021-2032) Figure 27. North America Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Hyaluronic Acid for Osteoarthritis Sales Market Share by Country (2021-2032) Figure 29. U.S. Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Hyaluronic Acid for Osteoarthritis Sales Market Share by Country (2021-2032) Figure 34. Germany Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Hyaluronic Acid for Osteoarthritis Sales Market Share by Country (2021-2032) Figure 41. China Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales Market Share by Country (2021-2032) Figure 49. Brazil Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Hyaluronic Acid for Osteoarthritis Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Hyaluronic Acid for Osteoarthritis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Hyaluronic Acid for Osteoarthritis Revenue (2021-2032) & (US$ Million) Figure 60. North America Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Hyaluronic Acid for Osteoarthritis Revenue (2021-2032) & (US$ Million) Figure 62. Europe Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Hyaluronic Acid for Osteoarthritis Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hyaluronic Acid for Osteoarthritis Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hyaluronic Acid for Osteoarthritis Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Phase
  • Duplex
Applications
  • Knee Joint
  • Hip Joint
  • Shoulder Joint
  • Ankle Joint
  • Others
Companies covered
  • BIOVENTUS
  • Anika Therapeutics
  • BIOIBERICA
  • Biolevox
  • Bohus BioTech
  • Fidia Farma
  • Hangzhou Singclean Medical Products
  • ideolab
  • LG Chem
  • Vivacy
  • Xediton Pharmaceuticals
  • Deka
  • Ferring B.V.
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hyaluronic Acid for Osteoarthritis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hyaluronic Acid for Osteoarthritis Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hyaluronic Acid for Osteoarthritis Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hyaluronic Acid for Osteoarthritis Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hyaluronic Acid for Osteoarthritis Market Dynamics
  1. 2.1 Hyaluronic Acid for Osteoarthritis Industry Trends
  2. 2.2 Hyaluronic Acid for Osteoarthritis Industry Drivers
  3. 2.3 Hyaluronic Acid for Osteoarthritis Industry Opportunities and Challenges
  4. 2.4 Hyaluronic Acid for Osteoarthritis Industry Restraints
3 Hyaluronic Acid for Osteoarthritis Market by Manufacturers
  1. 3.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hyaluronic Acid for Osteoarthritis Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hyaluronic Acid for Osteoarthritis Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hyaluronic Acid for Osteoarthritis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hyaluronic Acid for Osteoarthritis Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hyaluronic Acid for Osteoarthritis Manufacturers, Product Type & Application
  7. 3.7 Global Hyaluronic Acid for Osteoarthritis Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hyaluronic Acid for Osteoarthritis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hyaluronic Acid for Osteoarthritis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hyaluronic Acid for Osteoarthritis Tier 1, Tier 2, and Tier 3
4 Hyaluronic Acid for Osteoarthritis Market by Type
  1. 4.1 Hyaluronic Acid for Osteoarthritis Type Introduction
  2. 4.1.1 Single-Phase
  3. 4.1.2 Duplex
  4. 4.2 Global Hyaluronic Acid for Osteoarthritis Sales by Type
  5. 4.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2021-2032)
  7. 4.2.3 Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hyaluronic Acid for Osteoarthritis Revenue by Type
  9. 4.3.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2021-2032)
  11. 4.3.3 Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2021-2032)
5 Hyaluronic Acid for Osteoarthritis Market by Application
  1. 5.1 Hyaluronic Acid for Osteoarthritis Application Introduction
  2. 5.1.1 Knee Joint
  3. 5.1.2 Hip Joint
  4. 5.1.3 Shoulder Joint
  5. 5.1.4 Ankle Joint
  6. 5.1.5 Others
  7. 5.2 Global Hyaluronic Acid for Osteoarthritis Sales by Application
  8. 5.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2021-2032)
  10. 5.2.3 Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2021-2032)
  11. 5.3 Global Hyaluronic Acid for Osteoarthritis Revenue by Application
  12. 5.3.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2021-2032)
  14. 5.3.3 Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2021-2032)
6 Global Hyaluronic Acid for Osteoarthritis Sales by Region
  1. 6.1 Global Hyaluronic Acid for Osteoarthritis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hyaluronic Acid for Osteoarthritis Sales by Region (2021-2032)
  3. 6.2.1 Global Hyaluronic Acid for Osteoarthritis Sales by Region (2021-2026)
  4. 6.2.2 Global Hyaluronic Acid for Osteoarthritis Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hyaluronic Acid for Osteoarthritis Revenue by Region
  1. 7.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Region
  2. 7.1.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Region (2021-2026)
  4. 7.1.3 Global Hyaluronic Acid for Osteoarthritis Revenue by Region (2027-2032)
  5. 7.1.4 Global Hyaluronic Acid for Osteoarthritis Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hyaluronic Acid for Osteoarthritis Revenue (2021-2032)
  8. 7.2.2 North America Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hyaluronic Acid for Osteoarthritis Revenue (2021-2032)
  11. 7.3.2 Europe Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hyaluronic Acid for Osteoarthritis Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BIOVENTUS
  2. 8.1.1 BIOVENTUS Company Information
  3. 8.1.2 BIOVENTUS Business Overview
  4. 8.1.3 BIOVENTUS Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BIOVENTUS Hyaluronic Acid for Osteoarthritis Product Portfolio
  6. 8.1.5 BIOVENTUS Recent Developments
  7. 8.2 Anika Therapeutics
  8. 8.2.1 Anika Therapeutics Company Information
  9. 8.2.2 Anika Therapeutics Business Overview
  10. 8.2.3 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Product Portfolio
  12. 8.2.5 Anika Therapeutics Recent Developments
  13. 8.3 BIOIBERICA
  14. 8.3.1 BIOIBERICA Company Information
  15. 8.3.2 BIOIBERICA Business Overview
  16. 8.3.3 BIOIBERICA Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BIOIBERICA Hyaluronic Acid for Osteoarthritis Product Portfolio
  18. 8.3.5 BIOIBERICA Recent Developments
  19. 8.4 Biolevox
  20. 8.4.1 Biolevox Company Information
  21. 8.4.2 Biolevox Business Overview
  22. 8.4.3 Biolevox Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biolevox Hyaluronic Acid for Osteoarthritis Product Portfolio
  24. 8.4.5 Biolevox Recent Developments
  25. 8.5 Bohus BioTech
  26. 8.5.1 Bohus BioTech Company Information
  27. 8.5.2 Bohus BioTech Business Overview
  28. 8.5.3 Bohus BioTech Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bohus BioTech Hyaluronic Acid for Osteoarthritis Product Portfolio
  30. 8.5.5 Bohus BioTech Recent Developments
  31. 8.6 Fidia Farma
  32. 8.6.1 Fidia Farma Company Information
  33. 8.6.2 Fidia Farma Business Overview
  34. 8.6.3 Fidia Farma Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fidia Farma Hyaluronic Acid for Osteoarthritis Product Portfolio
  36. 8.6.5 Fidia Farma Recent Developments
  37. 8.7 Hangzhou Singclean Medical Products
  38. 8.7.1 Hangzhou Singclean Medical Products Company Information
  39. 8.7.2 Hangzhou Singclean Medical Products Business Overview
  40. 8.7.3 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Product Portfolio
  42. 8.7.5 Hangzhou Singclean Medical Products Recent Developments
  43. 8.8 ideolab
  44. 8.8.1 ideolab Company Information
  45. 8.8.2 ideolab Business Overview
  46. 8.8.3 ideolab Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ideolab Hyaluronic Acid for Osteoarthritis Product Portfolio
  48. 8.8.5 ideolab Recent Developments
  49. 8.9 LG Chem
  50. 8.9.1 LG Chem Company Information
  51. 8.9.2 LG Chem Business Overview
  52. 8.9.3 LG Chem Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LG Chem Hyaluronic Acid for Osteoarthritis Product Portfolio
  54. 8.9.5 LG Chem Recent Developments
  55. 8.10 Vivacy
  56. 8.10.1 Vivacy Company Information
  57. 8.10.2 Vivacy Business Overview
  58. 8.10.3 Vivacy Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vivacy Hyaluronic Acid for Osteoarthritis Product Portfolio
  60. 8.10.5 Vivacy Recent Developments
  61. 8.11 Xediton Pharmaceuticals
  62. 8.11.1 Xediton Pharmaceuticals Company Information
  63. 8.11.2 Xediton Pharmaceuticals Business Overview
  64. 8.11.3 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Product Portfolio
  66. 8.11.5 Xediton Pharmaceuticals Recent Developments
  67. 8.12 Deka
  68. 8.12.1 Deka Company Information
  69. 8.12.2 Deka Business Overview
  70. 8.12.3 Deka Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Deka Hyaluronic Acid for Osteoarthritis Product Portfolio
  72. 8.12.5 Deka Recent Developments
  73. 8.13 Ferring B.V.
  74. 8.13.1 Ferring B.V. Company Information
  75. 8.13.2 Ferring B.V. Business Overview
  76. 8.13.3 Ferring B.V. Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ferring B.V. Hyaluronic Acid for Osteoarthritis Product Portfolio
  78. 8.13.5 Ferring B.V. Recent Developments
  79. 8.14 Sanofi
  80. 8.14.1 Sanofi Company Information
  81. 8.14.2 Sanofi Business Overview
  82. 8.14.3 Sanofi Hyaluronic Acid for Osteoarthritis Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sanofi Hyaluronic Acid for Osteoarthritis Product Portfolio
  84. 8.14.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hyaluronic Acid for Osteoarthritis Value Chain Analysis
  2. 9.1.1 Hyaluronic Acid for Osteoarthritis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hyaluronic Acid for Osteoarthritis Production Mode & Process
  6. 9.2 Hyaluronic Acid for Osteoarthritis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hyaluronic Acid for Osteoarthritis Distributors
  9. 9.2.3 Hyaluronic Acid for Osteoarthritis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research